Qualigen Therapeutics (QLGN) Short Interest Ratio & Short Volume $4.18 +0.11 (+2.70%) As of 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Qualigen Therapeutics Short Interest DataQualigen Therapeutics (QLGN) has a short interest of 87,300 shares, representing 12.74% of the float (the number of shares available for trading by the public). This marks a -10.74% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 16,717 shares to cover all short positions.Current Short Interest87,300 sharesPrevious Short Interest97,800 sharesChange Vs. Previous Month-10.74%Dollar Volume Sold Short$367,533.00Short Interest Ratio0.9 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares740,000 sharesFloat Size685,200 sharesShort Percent of Float12.74%Today's Trading Volume15,306 sharesAverage Trading Volume16,717 sharesToday's Volume Vs. Average92% Short Selling Qualigen Therapeutics? Sign up to receive the latest short interest report for Qualigen Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartQLGN Short Interest Over TimeQLGN Days to Cover Over TimeQLGN Percentage of Float Shorted Over Time Qualigen Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202487,300 shares $367,533.00 -10.7%12.7%0.9 $4.21 12/15/202497,800 shares $378,486.00 -2.4%14.3%1.1 $3.87 11/30/2024100,200 shares $462,924.00 +6.1%15.0%1.2 $4.62 11/15/202494,400 shares $339,840.00 +505.1%14.1%1.1 $3.60 10/31/202415,600 shares $76,908.00 -85.8%3.1%0.2 $4.93 10/15/2024110,200 shares $17,951.58 +1.1%0.5%0.2 $0.16 9/30/2024109,000 shares $18,584.50 -60.5%0.5%0 $0.17 9/15/2024275,600 shares $45,363.76 -55.1%1.3%0 $0.16 8/31/2024613,400 shares $115,073.84 +84.4%2.4%0 $0.19 8/15/2024332,600 shares $65,522.20 +38.8%2.9%0 $0.20 Get the Latest News and Ratings for QLGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024239,600 shares $53,263.08 -94.2%2.4%0 $0.22 7/15/20244,160,000 shares $1.61 million +627.9%40.9%0.3 $0.39 6/30/2024571,500 shares $98,469.45 +493.5%6.7%0.1 $0.17 6/15/202496,300 shares $19,163.70 +20.7%1.6%0.1 $0.20 5/31/202479,800 shares $21,546.00 +1.7%1.3%0.5 $0.27 5/15/202478,500 shares $24,083.80 +82.1%1.3%0.8 $0.31 4/30/202443,100 shares $12,921.38 -12.8%0.8%0.6 $0.30 4/15/202449,400 shares $15,808.00 -38.2%0.9%0.8 $0.32 3/31/202479,900 shares $31,960.00 +588.8%1.7%1.3 $0.40 3/15/202411,600 shares $4,294.32 +11.5%0.3%0.2 $0.37 2/29/202410,400 shares $4,785.04 -63.5%0.2%0.2 $0.46 2/15/202428,500 shares $13,523.25 -3.1%0.6%0.7 $0.47 1/31/202429,400 shares $15,452.64 -14.5%0.6%1.1 $0.53 1/15/202434,400 shares $17,595.60 +63.8%0.8%1.3 $0.51 12/31/202321,000 shares $11,550.00 -32.7%0.5%0.9 $0.55 12/15/202331,200 shares $18,033.60 -8.0%0.7%1.6 $0.58 11/30/202333,900 shares $25,052.10 -15.9%0.7%2.5 $0.74 11/15/202340,300 shares $28,250.30 +0.8%0.9%2.7 $0.70 10/31/202340,000 shares $31,108.00 +5.5%0.9%2.7 $0.78 10/15/202337,900 shares $35,091.61 -14.5%0.9%1.9 $0.93 9/30/202344,300 shares $44,743.00 +23.1%1.0%1.7 $1.01 9/15/202336,000 shares $37,800.00 +77.3%0.8%1.4 $1.05 8/31/202320,300 shares $21,112.00 -9.8%0.5%0.8 $1.04 8/15/202322,500 shares $24,525.00 -37.0%0.5%0.9 $1.09 7/31/202335,700 shares $40,341.00 +28.4%0.8%1.2 $1.13 7/15/202327,800 shares $30,749.58 -12.3%0.6%1.1 $1.11 6/30/202331,700 shares $28,878.70 +26.3%0.7%1.1 $0.91 6/15/202325,100 shares $24,098.51 -38.6%0.6%0.7 $0.96 5/31/202340,900 shares $37,746.61 +7.4%0.9%0.2 $0.92 5/15/202338,100 shares $38,862.00 -39.9%0.9%0.2 $1.02URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 4/30/202363,400 shares $59,507.24 -5.4%1.5%0.4 $0.94 4/15/202367,000 shares $63,650.00 -19.2%1.8%0.4 $0.95 3/31/202382,900 shares $76,690.79 +48.8%2.2%0.2 $0.93 3/15/202355,700 shares $56,257.00 -31.0%1.5%0.2 $1.01 2/28/202380,700 shares $92,466.06 +41.6%2.1%0.3 $1.15 2/15/202357,000 shares $70,965.00 -17.2%1.5%0.2 $1.25 1/31/202368,800 shares $88,752.00 -61.2%1.8%0.3 $1.29 1/15/2023177,200 shares $237,448.00 +84.8%4.6%0.8 $1.34 12/30/202295,900 shares $123,615.10 No Change2.5%0.5 $1.29 12/15/202295,900 shares $136,178.00 +18.1%2.5%3.7 $1.42 11/30/202281,200 shares $121,597.00 -11.8%2.1%3.1 $1.50 11/15/202292,100 shares $20,308.05 -90.0%N/A4.3 $0.22 10/31/2022916,300 shares $201,586.00 -2.7%N/A4.3 $0.22 10/15/2022941,700 shares $253,128.96 -15.9%N/A4 $0.27 9/30/20221,120,000 shares $299,040.00 +25.5%N/A4.7 $0.27 9/15/2022892,200 shares $291,927.84 -11.7%N/A3.6 $0.33 8/31/20221,010,000 shares $384,406.00 -1.0%N/A4.3 $0.38 8/15/20221,020,000 shares $433,500.00 -8.9%N/A4.5 $0.43 7/31/20221,120,000 shares $469,056.00 -2.6%N/A4.8 $0.42 7/15/20221,150,000 shares $535,670.00 -2.5%N/A5.1 $0.47 6/30/20221,180,000 shares $672,246.00 -9.9%N/A1 $0.57 6/15/20221,310,000 shares $793,467.00 -9.0%N/A1.2 $0.61 5/31/20221,440,000 shares $807,840.00 +2.1%N/A1.3 $0.56 5/15/20221,410,000 shares $751,530.00 +13.7%N/A1.2 $0.53 4/30/20221,240,000 shares $706,800.00 -43.9%N/A1.1 $0.57 4/15/20222,210,000 shares $1.60 million +63.7%N/A1.8 $0.73 3/31/20221,350,000 shares $891,000.00 +3.9%N/A3.9 $0.66 3/15/20221,300,000 shares $741,000.00 -3.7%N/A0.7 $0.57 2/28/20221,350,000 shares $891,000.00 +2.3%N/A0.6 $0.66 2/15/20221,320,000 shares $970,860.00 -7.0%N/A0.2 $0.74 1/31/20221,420,000 shares $1.24 million -7.8%N/A0.2 $0.87 1/15/20221,540,000 shares $1.62 million -36.1%5.8%0.2 $1.05 12/31/20212,410,000 shares $2.58 million +33.9%9.3%0.3 $1.07 12/15/20211,800,000 shares $1.74 million -68.4%6.9%0.2 $0.96 11/30/20215,700,000 shares $8.38 million +258.5%22.1%0.8 $1.47 11/15/20211,590,000 shares $1.70 million -7.0%6.2%0.3 $1.07 10/29/20211,710,000 shares $1.97 million +4.3%6.7%3.8 $1.15 10/15/20211,640,000 shares $1.92 million -0.6%6.4%3.7 $1.17 9/30/20211,650,000 shares $2.15 million -0.6%6.4%3.5 $1.30 9/15/20211,660,000 shares $2.39 million +16.9%6.5%3.3 $1.44 8/31/20211,420,000 shares $2.23 million -18.9%5.5%2.7 $1.57 8/13/20211,750,000 shares $3.12 million -1.1%6.8%5.2 $1.78 7/30/20211,770,000 shares $3.13 million +2.3%6.9%5 $1.77 7/15/20211,730,000 shares $2.92 million +4.2%6.8%3.4 $1.69 6/30/20211,660,000 shares $3.30 million +9.2%6.5%2.7 $1.99 6/15/20211,520,000 shares $3.19 million -16.0%6.0%2.3 $2.10 5/28/20211,810,000 shares $3.46 million +0.6%7.1%2.5 $1.91 5/14/20211,800,000 shares $2.75 million -6.3%7.1%2.1 $1.53 4/30/20211,920,000 shares $4.22 million +7.9%7.5%1.6 $2.20 4/15/20211,780,000 shares $3.65 million No Change6.3%1.1 $2.05URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 3/31/20211,780,000 shares $4.63 million -11.4%6.2%1.1 $2.60 3/15/20212,010,000 shares $6.69 million +24.8%7.6%1.2 $3.33 2/26/20211,610,000 shares $5.47 million -10.6%6.1%0.8 $3.40 2/12/20211,800,000 shares $6.98 million -9.6%6.8%1 $3.88 1/29/20211,990,000 shares $7.12 million +3.7%7.5%1.2 $3.58 1/15/20211,920,000 shares $6.62 million No Change7.3%1.5 $3.45 QLGN Short Interest - Frequently Asked Questions What is Qualigen Therapeutics' current short interest? Short interest is the volume of Qualigen Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 87,300 shares of QLGN short. 12.74% of Qualigen Therapeutics' shares are currently sold short. Learn More on Qualigen Therapeutics' current short interest. What is a good short interest ratio for Qualigen Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. QLGN shares currently have a short interest ratio of 1.0. Learn More on Qualigen Therapeutics's short interest ratio. What is a good short interest percentage for Qualigen Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.74% of Qualigen Therapeutics' floating shares are currently sold short. Is Qualigen Therapeutics' short interest increasing or decreasing? Qualigen Therapeutics saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 87,300 shares, a drop of 10.7% from the previous total of 97,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Qualigen Therapeutics' float size? Qualigen Therapeutics currently has issued a total of 740,000 shares. Some of Qualigen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Qualigen Therapeutics currently has a public float of 685,200 shares. How does Qualigen Therapeutics' short interest compare to its competitors? 12.74% of Qualigen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Qualigen Therapeutics: TherapeuticsMD, Inc. (0.11%), Acurx Pharmaceuticals, Inc. (2.76%), Apollomics, Inc. (1.59%), Cellectar Biosciences, Inc. (4.70%), Brainstorm Cell Therapeutics Inc. (2.11%), Turnstone Biologics Corp. (3.24%), BioLineRx Ltd. (1.03%), Jaguar Health, Inc. (6.17%), Mustang Bio, Inc. (0.85%), Eyenovia, Inc. (4.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Qualigen Therapeutics stock? Short selling QLGN is an investing strategy that aims to generate trading profit from Qualigen Therapeutics as its price is falling. QLGN shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Qualigen Therapeutics? A short squeeze for Qualigen Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QLGN, which in turn drives the price of the stock up even further. How often is Qualigen Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QLGN, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies TherapeuticsMD Short Interest Data Acurx Pharmaceuticals Short Interest Data Apollomics Short Interest Data Cellectar Biosciences Short Interest Data Brainstorm Cell Therapeutics Short Interest Data Turnstone Biologics Short Interest Data BioLineRx Short Interest Data Jaguar Health Short Interest Data Mustang Bio Short Interest Data Eyenovia Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:QLGN) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QLGN Stock Alerts